Metraipolis › archive › dc_8a2264bc32d6

Herpesviridae Reactivation and Therapeutic Outcomes in Patients with Ulcerative Colitis Treated with Tofacitinib — Europe PMC PMID:42795896

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42795896
DOI
10.3390/jcm15187123
License (as archived)
solo-consultazione
Archived
2026-10-10T02:37:06.617Z
SHA-256 of the archived text
7e724269f29a53f646ecf00a93a694fe89db41738f1fefb8a8d07c7e47f90127
Stable URL of this page
https://metraipolis.com/documento/dc_8a2264bc32d6

How to cite

Herpesviridae Reactivation and Therapeutic Outcomes in Patients with Ulcerative Colitis Treated with Tofacitinib — Europe PMC PMID:42795896 — Europe PMC (en), https://europepmc.org/article/MED/42795896 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8a2264bc32d6 (Metraipolis archive dc_8a2264bc32d6, sha256 7e724269f29a53f646ecf00a93a694fe89db41738f1fefb8a8d07c7e47f90127)
BibTeX
@misc{dc8a2264bc32d6,
  title = {Herpesviridae Reactivation and Therapeutic Outcomes in Patients with Ulcerative Colitis Treated with Tofacitinib — Europe PMC PMID:42795896},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42795896},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8a2264bc32d6; sha256 7e724269f29a53f646ecf00a93a694fe89db41738f1fefb8a8d07c7e47f90127},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42795896. Agents can read the archived copy with the MCP tool read_document.